Figure 7.
Figure 7. VCAM-1+ICAM-1+ stromal cells provide Notch ligands within the fetal liver. CD45– stromal cells from E12 fetal liver were subdivided into subsets on the basis of expression of EpCAM1, ICAM-1, and VCAM-1. (A) EpCAM1 expression in CD45–ICAM-1–VCAM-1– cells; (B) ICAM-1 and VCAM-1 expression in CD45–EpCAM1– cells. Percentages shown are of the CD45– population. Such populations were sorted by MoFlo and analyzed for expression of Notch ligands by PCR (C-F). Note that expression of DL1 and DL4 by ICAM-1+VCAM-1+ fetal liver stromal cells (□) is similar to that of thymic epithelial cells (▪). ▦ indicates CD45–VCAM1–ICAM1–EpCAM1+ fetal liver cells. Similar data were produced from 3 separate experiments, and are expressed as mean ± SEM.

VCAM-1+ICAM-1+stromal cells provide Notch ligands within the fetal liver. CD45 stromal cells from E12 fetal liver were subdivided into subsets on the basis of expression of EpCAM1, ICAM-1, and VCAM-1. (A) EpCAM1 expression in CD45ICAM-1VCAM-1 cells; (B) ICAM-1 and VCAM-1 expression in CD45EpCAM1 cells. Percentages shown are of the CD45 population. Such populations were sorted by MoFlo and analyzed for expression of Notch ligands by PCR (C-F). Note that expression of DL1 and DL4 by ICAM-1+VCAM-1+ fetal liver stromal cells (□) is similar to that of thymic epithelial cells (▪). ▦ indicates CD45VCAM1ICAM1EpCAM1+ fetal liver cells. Similar data were produced from 3 separate experiments, and are expressed as mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal